This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $3,094.80 and an ultimate completion date of February 3, 2025. DMS Pharmaceutical Group Inc. also holds a significant single-award Indefinite...
This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $4,642.20 and an ultimate completion date of October 10, 2024. It is part of a larger...
The U.S. government's Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the purchase of Xolair 150 mg/mL auto-injectors, with a ceiling value of $20,546.64. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of XOLAIR 150 MG/ML AUTOINJECTORML, with a ceiling value of $1,712.22 and a term ending on February 24, 2025. The contract is a firm fixed-price delivery order and is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to...
This federal contract award is for the delivery of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at up to $3,868.50, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with...
This federal contract award is for the delivery of XOLAIR 75 MG/0.5 ML AUTOINJECT 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,405.36, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
This federal contract award is for the delivery of Xolair 300 mg/2 ml autoinjector medication to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $46,230.21, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's larger indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract is for the supply of XOLAIR 150 MG/ML SYRINGE, a biologic medication, to support the recurring medical needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to...
This federal contract award is for the delivery of XOLAIR 150 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,547.40, was awarded to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract, contract...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 mg/mL syringes. The contract has a ceiling value of $3,094.80 and a period of performance through July 29, 2024. This contract was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which supports the recurring pharmaceutical supply...